14-64449447-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005956.4(MTHFD1):​c.2282C>T​(p.Thr761Met) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00633 in 1,613,056 control chromosomes in the GnomAD database, including 362 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. T761T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.026 ( 152 hom., cov: 32)
Exomes 𝑓: 0.0043 ( 210 hom. )

Consequence

MTHFD1
NM_005956.4 missense, splice_region

Scores

4
6
6

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 6.09

Publications

15 publications found
Variant links:
Genes affected
MTHFD1 (HGNC:7432): (methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1) This gene encodes a protein that possesses three distinct enzymatic activities, 5,10-methylenetetrahydrofolate dehydrogenase, 5,10-methenyltetrahydrofolate cyclohydrolase and 10-formyltetrahydrofolate synthetase. Each of these activities catalyzes one of three sequential reactions in the interconversion of 1-carbon derivatives of tetrahydrofolate, which are substrates for methionine, thymidylate, and de novo purine syntheses. The trifunctional enzymatic activities are conferred by two major domains, an aminoterminal portion containing the dehydrogenase and cyclohydrolase activities and a larger synthetase domain. [provided by RefSeq, Jul 2008]
ZBTB25 (HGNC:13112): (zinc finger and BTB domain containing 25) Predicted to enable DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008836538).
BP6
Variant 14-64449447-C-T is Benign according to our data. Variant chr14-64449447-C-T is described in ClinVar as Benign. ClinVar VariationId is 1166610.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0844 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MTHFD1NM_005956.4 linkc.2282C>T p.Thr761Met missense_variant, splice_region_variant Exon 24 of 28 ENST00000652337.1 NP_005947.3 P11586
MTHFD1NM_001364837.1 linkc.2282C>T p.Thr761Met missense_variant, splice_region_variant Exon 24 of 27 NP_001351766.1
ZBTB25NM_001304508.1 linkc.*104G>A 3_prime_UTR_variant Exon 3 of 3 NP_001291437.1 G3V2K3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MTHFD1ENST00000652337.1 linkc.2282C>T p.Thr761Met missense_variant, splice_region_variant Exon 24 of 28 NM_005956.4 ENSP00000498336.1 P11586

Frequencies

GnomAD3 genomes
AF:
0.0261
AC:
3973
AN:
152152
Hom.:
151
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0868
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0122
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0277
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000323
Gnomad OTH
AF:
0.0162
GnomAD2 exomes
AF:
0.00987
AC:
2478
AN:
251140
AF XY:
0.00882
show subpopulations
Gnomad AFR exome
AF:
0.0911
Gnomad AMR exome
AF:
0.00575
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000361
Gnomad OTH exome
AF:
0.00539
GnomAD4 exome
AF:
0.00427
AC:
6233
AN:
1460786
Hom.:
210
Cov.:
30
AF XY:
0.00451
AC XY:
3280
AN XY:
726696
show subpopulations
African (AFR)
AF:
0.0947
AC:
3168
AN:
33446
American (AMR)
AF:
0.00599
AC:
268
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39700
South Asian (SAS)
AF:
0.0230
AC:
1984
AN:
86206
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53400
Middle Eastern (MID)
AF:
0.00630
AC:
31
AN:
4918
European-Non Finnish (NFE)
AF:
0.000300
AC:
334
AN:
1111960
Other (OTH)
AF:
0.00735
AC:
443
AN:
60296
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
349
698
1048
1397
1746
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
134
268
402
536
670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0262
AC:
3984
AN:
152270
Hom.:
152
Cov.:
32
AF XY:
0.0255
AC XY:
1901
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.0868
AC:
3605
AN:
41530
American (AMR)
AF:
0.0122
AC:
187
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.0275
AC:
133
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000323
AC:
22
AN:
68024
Other (OTH)
AF:
0.0161
AC:
34
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
198
395
593
790
988
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00903
Hom.:
195
Bravo
AF:
0.0296
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.0892
AC:
393
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.0118
AC:
1438
Asia WGS
AF:
0.0130
AC:
46
AN:
3478
EpiCase
AF:
0.000491
EpiControl
AF:
0.000771

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.097
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Uncertain
-0.060
CADD
Pathogenic
27
DANN
Uncertain
1.0
Eigen
Pathogenic
0.79
Eigen_PC
Uncertain
0.65
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.91
.;D
MetaRNN
Benign
0.0088
T;T
MetaSVM
Benign
-0.78
T
PhyloP100
6.1
PrimateAI
Benign
0.48
T
PROVEAN
Pathogenic
-4.7
D;.
REVEL
Uncertain
0.35
Sift
Pathogenic
0.0
D;.
Sift4G
Uncertain
0.0050
D;D
Polyphen
1.0
D;.
Vest4
0.20
MPC
0.54
ClinPred
0.086
T
GERP RS
5.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=41/59
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10813; hg19: chr14-64916165; COSMIC: COSV53700086; COSMIC: COSV53700086; API